Concepedia

Jing Christine Ye

JC

Statistics

Publications

15

Citations

598

H-Index

12

Active since

2019

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Icahn School of Medicine at Mount Sinai

University of Michigan

Janssen (United States)

Amsterdam University Medical Centers

Jing Christine Ye is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, relapsed multiple myeloma, and multiple myeloma.

Publications per year

2019–2025

15

Publications

15

Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

Naresh Bumma, Joshua Richter, Sundar Jagannath et al. · Journal of Clinical Oncology · 2024 · 135 citations · Full text

, , +16

Pivotal phase 2 MonumenTAL-1 results of talquetamab (tal), a GPRC5DxCD3 bispecific antibody (BsAb), for relapsed/refractory multiple myeloma (RRMM).

Carolina Schinke, Cyrille Touzeau, Monique C. Minnema et al. · Journal of Clinical Oncology · 2023 · 89 citations

, , +16

Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study

Ajai Chari, Cyrille Touzeau, Carolina Schinke et al. · The Lancet Haematology · 2025 · 83 citations · Full text

, , +12

LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma.

Hans C. Lee, Naresh Bumma, Joshua Richter et al. · Journal of Clinical Oncology · 2023 · 57 citations

, , +17

Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab

Ajai Chari, Amrita Krishnan, Leo Rasche et al. · Clinical Lymphoma Myeloma & Leukemia · 2024 · 41 citations · Full text

, , +17

1–5 of 15